Chemcon Speciality Chemicals Limited (NSE:CHEMCON)
India · Delayed Price · Currency is INR 188.60
-2.66 (-1.39%)
Aug 14, 2026, 10:09 AM IST
NSE:CHEMCON Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 2,529 | 2,400 | 2,074 | 2,671 | 3,029 | 2,571 |
Other Revenue | - | - | 0.19 | - | - | - |
| 2,529 | 2,400 | 2,074 | 2,671 | 3,029 | 2,571 | |
Revenue Growth | 17.43% | 15.70% | -22.34% | -11.82% | 17.80% | 5.59% |
Cost of Revenue | 1,613 | 1,559 | 1,232 | 1,912 | 1,779 | 1,263 |
Gross Profit | 916.47 | 840.93 | 842.59 | 758.95 | 1,250 | 1,308 |
Selling, General & Admin | 207.89 | 200.63 | 198.56 | 185.16 | 209.31 | 194.46 |
Other Operating Expenses | 330.32 | 338.58 | 314.25 | 299.92 | 333.03 | 290.62 |
Operating Expenses | 664 | 654.74 | 617.92 | 588.17 | 626.05 | 547.78 |
Operating Income | 252.47 | 186.19 | 224.67 | 170.78 | 623.6 | 760.58 |
Interest Expense | -26.26 | -21.13 | -34.49 | -34.55 | -14.34 | -5.4 |
Interest & Investment Income | - | - | 133.53 | 122.28 | 94.37 | 81.47 |
Currency Exchange Gain (Loss) | - | - | 8.49 | 4.21 | 32.06 | 10.76 |
Other Non Operating Income (Expenses) | 154.6 | 154.53 | -0.44 | -0.42 | -0.36 | -0.29 |
EBT Excluding Unusual Items | 380.8 | 319.59 | 331.75 | 262.31 | 735.32 | 847.12 |
Gain (Loss) on Sale of Investments | - | - | 0.73 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | -0.41 | 0.27 | 6.53 | -3.09 |
Asset Writedown | - | - | -0.61 | - | -0.34 | -4.08 |
Pretax Income | 380.8 | 319.59 | 331.46 | 262.58 | 741.51 | 839.96 |
Income Tax Expense | 99.06 | 83.61 | 86.94 | 70.65 | 190.41 | 212.39 |
Net Income | 281.74 | 235.98 | 244.52 | 191.93 | 551.1 | 627.57 |
Net Income to Common | 281.74 | 235.98 | 244.52 | 191.93 | 551.1 | 627.57 |
Net Income Growth | 10.62% | -3.49% | 27.40% | -65.17% | -12.18% | 11.27% |
Shares Outstanding (Basic) | 37 | 37 | 37 | 37 | 37 | 37 |
Shares Outstanding (Diluted) | 37 | 37 | 37 | 37 | 37 | 37 |
Shares Change | -0.05% | 0.03% | - | - | -0.00% | 7.03% |
EPS (Basic) | 7.69 | 6.44 | 6.68 | 5.24 | 15.04 | 17.13 |
EPS (Diluted) | 7.69 | 6.44 | 6.68 | 5.24 | 15.04 | 17.13 |
EPS Growth | 10.67% | -3.52% | 27.40% | -65.16% | -12.20% | 3.95% |
Free Cash Flow | - | 323.55 | 309.45 | -308.77 | -334.54 | 240.41 |
Free Cash Flow Per Share | - | 8.83 | 8.45 | -8.43 | -9.13 | 6.56 |
Dividend Per Share | - | 6.500 | - | - | 4.000 | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 36.23% | 35.04% | 40.62% | 28.42% | 41.26% | 50.89% |
Operating Margin | 9.98% | 7.76% | 10.83% | 6.39% | 20.59% | 29.58% |
Profit Margin | 11.14% | 9.83% | 11.79% | 7.19% | 18.20% | 24.41% |
Free Cash Flow Margin | - | 13.48% | 14.92% | -11.56% | -11.04% | 9.35% |
EBITDA | 370.62 | 301.72 | 329.72 | 273.44 | 704.77 | 819.65 |
EBITDA Margin | 14.65% | 12.57% | 15.90% | 10.24% | 23.27% | 31.88% |
D&A For EBITDA | 118.15 | 115.53 | 105.06 | 102.66 | 81.17 | 59.07 |
EBIT | 252.47 | 186.19 | 224.67 | 170.78 | 623.6 | 760.58 |
EBIT Margin | 9.98% | 7.76% | 10.83% | 6.39% | 20.59% | 29.58% |
Effective Tax Rate | 26.01% | 26.16% | 26.23% | 26.91% | 25.68% | 25.29% |
Revenue as Reported | 2,684 | 2,554 | 2,217 | 2,803 | 3,162 | 2,663 |